The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 21, 2018

Filed:

Aug. 08, 2013
Applicants:

Tsinghua University, Beijing, CN;

Protgen Ltd., Beijing, CN;

Inventors:

Yongzhang Luo, Beijing, CN;

Wei Zhuo, Beijing, CN;

Yan Fu, Beijing, CN;

Guodong Chang, Beijing, CN;

Assignees:

Tsinghua University, Beijing, CN;

Protgen Ltd., Beijing, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C07K 16/28 (2006.01); A61K 38/39 (2006.01);
U.S. Cl.
CPC ...
G01N 33/574 (2013.01); C07K 16/28 (2013.01); A61K 38/39 (2013.01); C07K 2317/76 (2013.01); G01N 2333/515 (2013.01); G01N 2800/52 (2013.01); G01N 2800/56 (2013.01); G01N 2800/7014 (2013.01);
Abstract

The present invention relates to a method of identifying cancer subjects, in particular human patients, who are suitable for anti-lymphangiogenesis therapy to prevent tumor growth and tumor metastasis. The present invention also relates to a new approach, which uses nucleolin as a bait to search and screen for lymphangiogenesis inhibitors or cancer suppressors, which function in a manner that is analogous to endostatin. The invention is based upon the discovery that nucleolin is specifically expressed on lymphangiogenic vessels and functions as a specific receptor for endostatin, and thus is involved in the signal transduction pathway of endostatin as an anti-lymphangiogenesis inhibitor. The present invention also discloses that cell surface nucleolin on lymphatic endothelial cells is a biomarker for lymphangiogenic vessels, which could be used for the prediction of tumor metastasis.


Find Patent Forward Citations

Loading…